TrueMark Investments’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,859
Closed -$409K 175
2025
Q4
$409K Buy
+28,859
New +$418K 0.08% 159

Other funds holding BCAT

TrueMark Investments's BCAT Position: Q1 2026 in Review

TrueMark Investments sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 28,859 shares — an estimated $409K sold.

TrueMark Investments first reported a position in BCAT in Q4 2025 and held it in 1 quarter. The position peaked at $409K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • TrueMark Investments reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
  • TrueMark Investments sold 28,859 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $409K.
  • TrueMark Investments first reported a position in BlackRock Capital Allocation Term Trust in Q4 2025 and held it in 1 quarter.
  • TrueMark Investments's BlackRock Capital Allocation Term Trust position peaked at $409K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.